News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
413,578 Results
Type
Article (48036)
Company Profile (80)
Press Release (365462)
Multimedia
Podcasts (20)
Webinars (10)
Section
Business (118691)
Career Advice (1326)
Deals (16740)
Drug Delivery (45)
Drug Development (50098)
Employer Resources (94)
FDA (8360)
Job Trends (9248)
News (194133)
Policy (15197)
Tag
Academia (2633)
Academic (1)
Accelerated approval (4)
Adcomms (7)
Allergies (47)
Alliances (34250)
ALS (66)
Alzheimer's disease (1148)
Antibody-drug conjugate (ADC) (81)
Approvals (8398)
Artificial intelligence (179)
Autoimmune disease (11)
Automation (7)
Bankruptcy (102)
Best Places to Work (7229)
BIOSECURE Act (11)
Biosimilars (35)
Biotechnology (53)
Bladder cancer (41)
Brain cancer (24)
Breast cancer (182)
Cancer (1595)
Cardiovascular disease (92)
Career advice (1110)
Career pathing (21)
CAR-T (106)
Cell therapy (273)
Cervical cancer (10)
Clinical research (39299)
Collaboration (646)
Compensation (70)
Complete response letters (6)
COVID-19 (1891)
CRISPR (32)
C-suite (138)
Cystic fibrosis (65)
Data (1577)
Decentralized trials (2)
Denatured (8)
Depression (29)
Diabetes (155)
Diagnostics (3915)
Digital health (11)
Diversity (4)
Diversity, equity & inclusion (25)
Drug discovery (96)
Drug pricing (48)
Drug shortages (6)
Duchenne muscular dystrophy (49)
Earnings (42885)
Editorial (20)
Employer branding (14)
Employer resources (82)
Events (49900)
Executive appointments (461)
FDA (9062)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (3)
Frontotemporal dementia (5)
Funding (486)
Gene editing (64)
Generative AI (16)
Gene therapy (198)
GLP-1 (404)
Government (2315)
Grass and pollen (2)
Guidances (36)
Healthcare (11166)
Huntington's disease (10)
IgA nephropathy (9)
Immunology and inflammation (54)
Indications (20)
Infectious disease (1981)
Inflammatory bowel disease (91)
Inflation Reduction Act (4)
Influenza (40)
Intellectual property (60)
Interviews (262)
IPO (7697)
IRA (28)
Job creations (2322)
Job search strategy (958)
Kidney cancer (6)
Labor market (23)
Layoffs (277)
Leadership (8)
Legal (2811)
Liver cancer (35)
Lung cancer (223)
Lymphoma (116)
Machine learning (5)
Management (29)
Manufacturing (177)
MASH (48)
Medical device (6310)
Medtech (6313)
Mergers & acquisitions (9378)
Metabolic disorders (357)
Multiple sclerosis (54)
NASH (11)
Neurodegenerative disease (53)
Neuropsychiatric disorders (11)
Neuroscience (1510)
NextGen: Class of 2025 (3489)
Non-profit (3647)
Now hiring (24)
Obesity (153)
Opinion (148)
Ovarian cancer (61)
Pain (43)
Pancreatic cancer (52)
Parkinson's disease (106)
Partnered (16)
Patents (124)
Patient recruitment (70)
Peanut (27)
People (35482)
Pharmaceutical (20)
Pharmacy benefit managers (4)
Phase I (12291)
Phase II (16773)
Phase III (13234)
Pipeline (918)
Policy (81)
Postmarket research (1900)
Preclinical (6792)
Press Release (65)
Prostate cancer (68)
Psychedelics (20)
Radiopharmaceuticals (164)
Rare diseases (208)
Real estate (3940)
Recruiting (35)
Regulatory (11230)
Reports (28)
Research institute (2510)
Resumes & cover letters (191)
Rett syndrome (1)
RNA editing (1)
RSV (21)
Schizophrenia (51)
Series A (72)
Series B (39)
Service/supplier (10)
Sickle cell disease (36)
Special edition (12)
Spinal muscular atrophy (103)
Sponsored (22)
Startups (2272)
Stomach cancer (4)
Supply chain (31)
Tariffs (17)
The Weekly (12)
Vaccines (475)
Venture capitalists (13)
Weight loss (81)
Women's health (17)
Worklife (9)
Date
Today (103)
Last 7 days (535)
Last 30 days (1558)
Last 365 days (19594)
2025 (6278)
2024 (20917)
2023 (24289)
2022 (33903)
2021 (35794)
2020 (33118)
2019 (27532)
2018 (20850)
2017 (19748)
2016 (19636)
2015 (23245)
2014 (17617)
2013 (15587)
2012 (15663)
2011 (16388)
2010 (15184)
Location
Africa (559)
Alabama (44)
Alaska (3)
Arizona (93)
Arkansas (5)
Asia (25228)
Australia (4799)
California (3388)
Canada (1229)
China (315)
Colorado (137)
Connecticut (163)
Delaware (82)
Europe (60131)
Florida (546)
Georgia (120)
Idaho (30)
Illinois (295)
India (23)
Indiana (197)
Iowa (7)
Japan (126)
Kansas (45)
Kentucky (11)
Louisiana (4)
Maine (19)
Maryland (512)
Massachusetts (2470)
Michigan (141)
Minnesota (172)
Mississippi (2)
Missouri (52)
Montana (16)
Nebraska (11)
Nevada (26)
New Hampshire (24)
New Jersey (1123)
New Mexico (27)
New York (1155)
North Carolina (642)
North Dakota (6)
Northern California (1495)
Ohio (134)
Oklahoma (8)
Oregon (14)
Pennsylvania (711)
Puerto Rico (3)
Rhode Island (18)
South America (620)
South Carolina (11)
Southern California (1310)
Tennessee (43)
Texas (544)
United States (13248)
Utah (91)
Virginia (94)
Washington D.C. (47)
Washington State (370)
West Virginia (1)
Wisconsin (34)
413,578 Results for "scripps research calibr division".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
Calibr-Skaggs announces expansion of option and license agreement with AbbVie to develop novel cell therapies for solid tumors and autoimmune diseases
The Calibr-Skaggs Institute for Innovative Medicines, the nonprofit drug development division of Scripps Research, announced today that AbbVie (NYSE: ABBV) has expanded its collaboration to further explore Calibr-Skaggs’ switchable CAR-T (sCAR-T) platform in solid tumor indications and autoimmune diseases.
February 6, 2024
·
3 min read
Press Releases
Scripps Research Advances Breakthrough Regenerative Medicines to Reverse Aging-Related Diseases
October 31, 2024
·
6 min read
Deals
Calibre Scientific Acquires DCS, a German Provider of Antibodies, Reagents and Equipment Used in Immunohistochemistry
Calibre Scientific is pleased to announce the acquisition of DCS Innovative Diagnostik-Systeme GmbH & Co. KG (“DCS” or the “Company”), a German supplier of reagents and equipment used in immunohistochemistry for the diagnostic, research, industrial, university and hospital industries, with a focus on clinical pathology and oncology end markets.
June 19, 2024
·
2 min read
Biotech Beach
Calibr and Bill & Melinda Gates Medical Research Institute announce licensing agreement for novel candidate tuberculosis treatment compound
Calibr, a division of Scripps Research dedicated to the “bench to bedside” development of transformative medicines, and the Bill & Melinda Gates Medical Research Institute, announced a strategic licensing agreement to advance development of a novel investigational compound for tuberculosis treatment.
February 15, 2023
·
4 min read
Press Releases
Alloy Therapeutics Announces Institutional License Agreement with Scripps Research for its ATX-Gx™ Platform for Fully Human Antibody Discovery
October 30, 2024
·
3 min read
Press Releases
Xenetic Biosciences, Inc. Extends Research and Development Collaboration with The Scripps Research Institute to Advance DNase Platform
November 8, 2024
·
6 min read
Deals
Calibre Scientific Acquires LineaLAB
Calibre Scientific has acquired LineaLAB, SL, a provider of analytical, bio and laboratory equipment based in Badalona.
January 2, 2024
·
4 min read
Layoffs
Entrada Cuts 20% of Workforce, Targeting Research Employees
Entrada is paring back its research staff even as it gears up to hire employees to support a planned clinical trial for a Duchenne muscular dystrophy candidate.
April 30, 2025
·
1 min read
·
Angela Gabriel
Press Releases
Scientific Industries Secures New Funding to Advance its SBI Bioprocessing Division
April 23, 2025
·
3 min read
Biotech Beach
Bruker Applied Mass Spectrometry Division Showcases High-Performance Solutions for Research and Analysis in Applied Laboratories
The Bruker Applied Mass Spectrometry Division is showcasing some of its latest innovations at ASMS 2024.
June 3, 2024
·
4 min read
1 of 41,358
Next
